Pulmonary Hypertension [Paperback]

This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments over the past decade. The discoveries of endothelin overexpression as well as prostacyclin and nitric oxide deficiency in association with pulmonary hypertension have led to important therapeutic insights. The new therapies have led to significant improvements in patient function, quality of life and survival. In this book, expert authors describe these new therapies. It will be of interest not only to cardiologists, pulmonary specialists and rheumatologists, but also many nurses and pharmacotherapists.

This timely volume addresses the areas of pathophysiology and therapy of pulmonary hypertension, which have seen exciting developments. Expert authors describe new therapies that have led to significant improvements in patient function and survival.

Chapter 1. Historical Perspective: A Century of Primary (Idiopathic) Pulmonary Hypertension.Alfred P. Fishman MDChapter 2: Classification of Pulmonary HypertensionC. William Hargett, MD and Victor F. Tapson, MD (2 Tables)Chapter 3. Diagnostic Approach to Pulmonary Arterial Hypertension (1 figure)Ronald J. Oudiz, MD, FACP, FACCChapter 4. Pathophysiology of Pulmonary Arterial HypertensionHarrison W. Farber, M.D.Chapter 5: Pulmonary Hypertension Genes (Check references)Elisabeth Donlevy Willers, MD and Ivan M. Robbins, MDChapter 6. The Right Ventricle in Pulmonary HypertensionAndrew C. Stone, MD and James R. Klinger, MDChapter 7. Congenital Heart Disease Associated Pulmonary Arterial HypertensionMichael J. Landzberg, MDChapter 8. Connective Tissue Disease Associated Pulmonary HypertensionKimberly Fisher, MD, Nicholas S. Hill, MD and Harrison Farber, MDChapter 9. Pulmonary Hypertension associated with HIV, Liver Disease, Sarcoidosis and Sickle Cell Disease.Kimberly A. Fisher, MD and Elizabeth S. Klings, MDChapter 10. Chronic Thromboembolic Pulmonary Hypertenl3)